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A direct interaction between proliferating cell nuclear antigen
(PCNA) and Cdk2 targets PCNA-interacting proteins for
phosphorylation
Abstract
Proliferating cell nuclear antigen is best known as a DNA polymerase accessory protein but has more
recently also been shown to have different functions in important cellular processes such as DNA
replication, DNA repair, and cell cycle control. PCNA has been found in quaternary complexes with the
cyclin kinase inhibitor p21 and several pairs of cyclin-dependent protein kinases and their regulatory
partner, the cyclins. Here we show a direct interaction between PCNA and Cdk2. This interaction
involves the regions of the PCNA trimer close to the C termini. We found that PCNA and Cdk2 form a
complex together with cyclin A. This ternary PCNA-Cdk2-cyclin A complex was able to phosphorylate
the PCNA binding region of the large subunit of replication factor C as well as DNA ligase I.
Furthermore, PCNA appears to be a connector between Cdk2 and DNA ligase I and to stimulate
phosphorylation of DNA ligase I. Based on our results, we propose the model that PCNA brings Cdk2
to proteins involved in DNA replication and possibly might act as an "adaptor" for Cdk2-cyclin A to
PCNA-binding DNA replication proteins.
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Proliferating cell nuclear antigen is best known as a
DNA polymerase accessory protein but has more re-
cently also been shown to have different functions in
important cellular processes such as DNA replication,
DNA repair, and cell cycle control. PCNA has been found
in quaternary complexes with the cyclin kinase inhibi-
tor p21 and several pairs of cyclin-dependent protein
kinases and their regulatory partner, the cyclins. Here
we show a direct interaction between PCNA and Cdk2.
This interaction involves the regions of the PCNA trimer
close to the C termini. We found that PCNA and Cdk2
form a complex together with cyclin A. This ternary
PCNA-Cdk2-cyclin A complex was able to phosphorylate
the PCNA binding region of the large subunit of repli-
cation factor C as well as DNA ligase I. Furthermore,
PCNA appears to be a connector between Cdk2 and DNA
ligase I and to stimulate phosphorylation of DNA ligase
I. Based on our results, we propose the model that PCNA
brings Cdk2 to proteins involved in DNA replication and
possibly might act as an “adaptor” for Cdk2-cyclin A to
PCNA-binding DNA replication proteins.
Proliferating cell nuclear antigen (PCNA)1 (1) was first char-
acterized as a processivity factor for DNA polymerase d. How-
ever, within the last few years many proteins besides poly-
merases d and e and the clamp loader replication factor C
(RF-C) have been found to interact with PCNA. They include
the flap-specific endonuclease Fen1 (2), the cyclin kinase inhib-
itor p21 (3), cyclins (4), the growth arrest and DNA damage
response protein Gadd45 (5), the DNA mismatch repair pro-
teins MSH2 and MLH1 (6), the nucleotide excision repair en-
donuclease XP-G (7), the human DNA-(cytosine-5) methyl-
transferase (8), and the human DNA ligase I (2). At the same
time, PCNA has been shown to have roles in cellular pathways
other than DNA replication, such as nucleotide excision repair,
mismatch repair, base excision repair, cell cycle control, apo-
ptosis, and transcription. All of these interactions led to the
idea that PCNA plays a central role in connecting all of these
important cellular processes and can act as a cellular commu-
nicator (9).
PCNA has furthermore been identified in quaternary com-
plexes with the kinase inhibitor p21, the cyclin-dependent pro-
tein kinases (Cdks), and their regulatory partners, the cyclins
(4). The pairs of Cdk-cyclin found in these complexes were
Cdk4-cyclin D, Cdk2-cyclin E, Cdk2-cyclin A, and Cdc2-cyclin
B. Cdks represent a family of protein kinases that control the
transition between successive phases of the cell cycle in all
eukaryotic cells (10). The G0 3 G1 transition is regulated by
Cdk4-cyclin D and Cdk6-cyclin D; G1 3 S transition by Cdk2-
cyclin E; the G2 and S phases by Cdk2-cyclin A; and the G2 3
M transition by Cdc2-cyclin B. The different Cdk-cyclin com-
plexes display distinct physiological functions. Cdk4-cyclin D
can phosphorylate the retinoblastoma gene product pRb, which
sequesters transcription factors, to allow the progression into S
phase (11). Proteins involved in DNA replication such as T
antigen (12), polymerase a/primase (13), polymerase d (14), and
replication protein A (15) are also substrates of Cdk-cyclin (16).
In mitosis, the nuclear lamina is disassembled by a direct
Cdc2-cyclin B phosphorylation (10). Since PCNA is found in a
complex with Cdks and can bind many proteins, the function of
the PCNA-Cdk2-cyclin A complex could function in attracting
proteins and in particular replication proteins as target for
kinases.
While searching for interacting partners with PCNA, we
found that Cdk2 can directly interact with PCNA. First, Myc-
tagged PCNA was transiently overexpressed in 293 cells and
immunoprecipitated by using an anti-Myc antibody. Co-immu-
noprecipitated proteins as well as polymerase d (p125 subunit
and p50 subunit), Lig I, Fen I, and p21 were detected by
immunoblotting. The interaction between PCNA and Cdk2 was
clearly confirmed by co-immunoprecipitation and surface plas-
mon resonance. Since the function of this complex is unknown,
we studied the PCNA-Cdk2 complex in more detail. The PCNA-
Cdk2 complex was present throughout the cell cycle as shown
by immunoprecipitation. Since both Cdk2 and PCNA are in-
volved in S phase events, PCNA was immunoprecipitated from
cell extracts to see if a Cdk-cyclin kinase activity can be co-
immunoprecipitated. The immunoprecipitation of PCNA from
nuclear cell extracts resulted in a PCNA-Cdk2-cyclin A com-
plex that was active in phosphorylating the PCNA binding
region of RF-Cp145 as well as Lig I. Finally, PCNA was found
to be necessary for binding of Lig I to Cdk2 and to stimulate
phosphorylation of Lig I by Cdk2-cyclin A, suggesting that
* This work was supported by Swiss National Science Foundation
Grant 3100-43138 95/2 (to S. K. and Z. O. J.) and Grant 31-57 285 99/99
(to S. H.) and European Training Mobility and Research (EU-TMR)
Project ERBMRXCT CT 970125 (to U. H., R. d. J., and P. v. d. V.), and
by the Kanton of Zu¨rich (to U. H. and M. O. H.). The costs of publication
of this article were defrayed in part by the payment of page charges.
This article must therefore be hereby marked “advertisement” in ac-
cordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed. Tel.: 41 1 635 54 72;
Fax: 41 1 635 68 40; E-mail: hubscher@vetbio.unizh.ch.
1 The abbreviations used are: PCNA, proliferating cell nuclear anti-
gen; RF-C, replication factor C; Cdk, cyclin-dependent kinase; Lig I,
DNA ligase I; FCS, fetal calf serum; GST, glutathione S-transferase.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 275, No. 30, Issue of July 28, pp. 22882–22887, 2000
© 2000 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www.jbc.org22882
PCNA might bring the Cdk2-cyclin A complex to its site(s) of
action.
EXPERIMENTAL PROCEDURES
Materials—For cell culture, Dulbecco’s modified Eagle’s medium,
fetal calf serum (FCS) and the solution of penicillin and streptomycin
were from Life Technologies, Inc. Hydroxyurea was from Sigma. Flow
cytometry analyses were done by using a FACScanTM flow cytometer
(Becton Dickinson). The IBIS system (Intersens Instruments BV,
Amersfoort, Holland) was used for surface plasmon resonance (17).
CM5 research grade sensor chips and coupling agents were purchased
from BIAcore (Upsala, Sweden).
Nucleic Acids—Poly(dA)1000–1500 was from Sigma, and oligo(dT) was
from Microsynth (Balgach, Switzerland). To generate constructs for
eukaryotic overexpression of wild type PCNA and PCNA mutants,
polymerase chain reaction primers were constructed to either generate
a single N-terminal Myc tag or a Kozak consensus sequence in front of
the PCNA open reading frame. Following polymerase chain reaction
amplification, the resulting fragments were cloned into either pCDNA3
(for N-Myc-PCNA) or pCDNA3.1 (for C-Myc-His-PCNA). All clones were
sequenced completely to confirm the absence of polymerase chain reac-
tion-induced errors. The pGEX-3X plasmids expressing human wild
type Cdk2 GST fusion protein and human wild type cyclin A GST fusion
protein were kindly provided by C. Bonne-Andre´a and R. Fotedar,
respectively. The plasmid pT7/PCNA was a gift of Bruce Stillman.
Proteins and Antibodies—Human wild type PCNA was produced in
E. coli using the plasmid pT7/hPCNA and purified to homogeneity as
described (18). Mutant PCNA proteins were purified as described (9).
The pCDNA3 derivative clones were used for transient expression of
Myc- or Myc-(poly-His)-tagged proteins. Cells were transfected accord-
ing to Hottiger and Nabel (19). The purified Cdk2-cyclin A complex (13)
was a gift from H. P. Nasheuer. The histone H1 was from Roche.
Anti-Cdk2 rabbit (H-298), anti-cyclin A rabbit (H-432), anti-PCNA
mouse (PC10), and anti-GST rabbit antibodies (Z-5) were from Santa
Cruz Biotechnology, Inc. (Santa Cruz, CA). The mouse IgG1,k (MOPC-
21) purified immunoglobulin from Sigma was used as negative control
for immunoprecipitation. The polyclonal antibody against human DNA
ligase I was a gift from T. Lindahl.
Cell Culture and Preparations of Cell Extracts—HeLa and 293 were
grown in Dulbecco’s modified Eagle’s medium supplemented with 10%
FCS, 10 mg/ml antibiotics (penicillin and streptomycin) at 37 °C under
an atmosphere of 5% CO2. For synchronization in G1, cells grown to
approximately 50% confluence were arrested by serum starvation in
Dulbecco’s modified Eagle’s medium supplemented with 0.5% FCS and
released at 2 h. S phase cells were harvested 2 h after release from a
24-h block with 2 mM hydroxyurea. The proportion of cells in the
various phases of the cell cycle was determined by flow cytometry. For
S-100 extracts, cells were resuspended in 50 mM Tris (pH 7.9), 5 mM
NaCl, 0.3% (v/v) Nonidet P-40, 0.5 mM phenylmethylsulfonyl fluoride,
0.5 mM dithiothreitol, 2 mg/ml each of pepstatin and leupeptin and
incubated for 30 min at 4 °C. After 10 min of centrifugation at 3000 3
g, the supernatant was adjusted to 120 mM NaCl and ultracentrifuged
at 100,000 3 g for 1 h.
For nuclear and cytoplasmic extracts (20), HeLa cells were grown to
approximately 60% confluence. Harvested cells were first lysed at 4 °C
in buffer A containing 10 mM Hepes (pH 7.9), 1.5 mM MgCl2, 10 mM KCl,
1 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, 0.1% (v/v)
Nonidet P-40, and 2 mg/ml each of leupeptin and pepstatin for 5 min.
The cytoplasmic extract was collected after 5 min of centrifugation at
8000 3 g and diluted 1:3 with buffer D (20 mM Hepes, pH 7.9, 0.5 mM
phenylmethylsulfonyl fluoride and 20% glycerol). The nuclei pelleted
were extracted for 15 min in buffer C containing 20 mM Hepes (pH 7.9),
0.42 M NaCl, 1.5 mM MgCl2, 1 mM dithiothreitol, 0.5 mM phenylmeth-
ylsulfonyl fluoride, 25% (v/v) glycerol, and 2 mg/ml each of leupeptin and
pepstatin and cleared by centrifugation at 12,000 3 g for 15 min. The
nuclear fraction was diluted 1:6 in buffer D.
Pull-down Assays—For in vitro binding, 10 ml of glutathione-Sepha-
rose beads were incubated with 10 mM of GST-proteins for 2 h at 4 °C.
GST-proteins bound to the beads were incubated with 100 ng of purified
PCNA or 100 mg of 293 S-100 extracts containing overexpressed wild
type and mutant His-PCNA. After 1 h at 4 °C, the beads were washed
four times with 50 mM Tris (pH 8), 150 mM NaCl, 0.5% (v/v) Nonidet
P-40, and 2 mg/ml each of leupeptin and aprotinin (binding buffer) at
4 °C, and bound proteins were eluted with 50 mM Tris (pH 6.8), 2 mM
EDTA, 1% (w/v) b-mercaptoethanol, 8% (v/v) glycerol, and 0.025% (w/v)
bromphenol blue (SDS sample buffer).
SPR Analysis—All experiments were performed at room tempera-
ture. Purified PCNA was covalently coupled to the dextran of a CM5
research grade sensor chip. The carboxymethylated dextran was acti-
vated for 5 min with 0.1 M N-hydroxysuccinimide and 0.4 M N-ethyl-
N9-(dimethylaminopropyl)carbodiimide in water. The ligand was then
injected on the reactive surface (100 ml of 0.8 mM PCNA) in 10 mM
NaCH3COOH (pH 5.3) and 20 mM NaCl. Afterward, the residual N-
hydroxysuccinide esters on the sensor chip surface were deactivated for
5 min with 1 M ethanolamine (pH 8.5) in water. Final regeneration of
the matrix was performed with 0.5 M NaCl and 0.025% (w/v) SDS.
Purified wild-type GST-Cdk2 and mutant proteins were diluted in 20
mM Tris (pH 8.0), 1 mM EDTA, 10 mM NaCl, 1 mM dithiothreitol, and
10% (v/v) glycerol. A 100-ml sample was injected over the PCNA-coupled
surface for 5 min. Multiple injections at various concentrations were
performed for each ligand. The association phases of the recorded sen-
sorgrams were fitted to a first order binding model (Rt 5 R0 1 (kaCRmax/
kS)(1 2 e
2k
St)) by nonlinear least squares curve fitting using the IBIS
kinetic evaluation software. At various concentrations of analyte, the kS
values were determined, and the association rate constant ka was
calculated by the linear curve fitting of a kS versus C plot (kS 5 kazC 1
kd).
Immunoprecipitation—150 mg of cytoplasmic HeLa, 50 mg of nuclear
HeLa, and 150 mg of S-100 HeLa extracts were adjusted to 40 mM
Hepes-KOH (pH 7.5), 8 mM MgCl2, 100 mM NaCl, 0.5% (v/v) Nonidet
P-40, 1 mg/ml each of aprotinin and leupeptin (IP buffer) and added to
a column coupled or preincubated with antibody. After a 2-h incubation
at 4 °C, the column was washed with IP buffer, and the bound proteins
were eluted with SDS sample buffer as described under “Pull-down
Assays.”
Immunoblotting—Protein samples were separated in a SDS-12%
polyacrylamide gel and transferred to nitrocellulose membrane (Micron
Separations Inc.) in 25 mM Tris, 192 mM glycine, and 20% methanol
using a Bio-Rad Trans Blot apparatus. After blocking with 5% milk in
10 mM Tris (pH 7.5), 150 mM NaCl and 0.05% (v/v) Tween 20 (TBST),
antibodies were incubated for 2 h and then washed in TBST. The
antigen/antibody reaction was revealed by using an enhanced chemilu-
minescence procedure according to the manufacturer’s recommendation
(Pierce).
Protein Kinase Assays—The assays were performed with purified
Cdk2-cyclin A complexes (13) or Cdk-cyclin complexes immunoprecipi-
tated. Protein G-Sepharose containing the immunocomplex was washed
with IP buffer and then with a solution containing 40 mM Hepes (pH
7.5) and 8 mM MgCl2 (kinase buffer). Assays were performed in a
reaction mixture of 18 ml containing kinase buffer, 33.3 mM ATP, 10 mCi
of [g-32P]ATP (3000 Ci/mmol; NEN Life Science Products), the sub-
strate (histone H1, RF-C B, or Lig I), and 10 ml of packed protein
G-Sepharose or purified Cdk2-cyclin A complexes. After 20 min at
37 °C, the reactions were stopped by adding SDS sample buffer
and loaded on a 12% SDS-polyacrylamide gel, electrophoresed for 90
min at 120 V, stained with Coomassie Brilliant Blue, dried, and
autoradiographed.
RESULTS
PCNA Can Form a Complex with Cdk2 and Cyclin A in the
Nucleus—We first performed co-immunoprecipitation of Myc-
tagged PCNA transiently overexpressed in 293 cells to discover
PCNA-interacting proteins. Since Cdk2 was clearly shown to
interact with PCNA, experiments were done to confirm the
interaction with endogenous proteins. For this purpose, cyto-
plasmic and nuclear extracts from unsynchronous HeLa cells
were immunoprecipitated using anti-Cdk2 and anti-cyclin A
antibodies. The immunoprecipitated complexes were analyzed
by immunoblotting with anti-Cdk2, anti-cyclin A, and anti-
PCNA antibodies. The anti-Cdk2 antibody co-precipitated cy-
clin A as well as PCNA from both nuclear and cytoplasmic
fractions (Fig. 1). While cyclin A was found in a complex with
Cdk2 in the nucleus as well as in the cytoplasm, a ternary
PCNA-Cdk2-cyclin A complex could only be found in the nu-
cleus, as seen in Fig. 1, when immunoprecipitation was per-
formed with anti-cyclin A antibody.
PCNA and Cdk2 Form a Complex in S Phase—Next we
addressed the question of whether the formation of the complex
between PCNA and Cdk2 is cell cycle-specific. For this, immu-
noprecipitations of Cdk2 were performed from cytoplasmic and
nuclear extracts of HeLa cells synchronized in G1 and S phase.
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The cells were synchronized in G1 phase by serum starvation
(0.5% FCS) followed by a release of 2 h and in S phase by
hydroxyurea block followed by a release of 2 h. The synchroni-
zation was analyzed by flow cytometry. The co-immunoprecipi-
tated complexes were identified by immunoblot, by using anti-
Cdk2 and anti-PCNA antibodies. When the majority of HeLa
cells are in G1 phase, PCNA and Cdk2 formed a complex in the
nucleus but not in the cytoplasm (Fig. 2A). The same result was
obtained by hydroxyurea block (data not shown). When most of
the cells are in S phase, the complex was found in the nucleus
as well as in the cytoplasm (Fig. 2B). These results suggested
that a PCNA-Cdk2 complex could be formed in the cytoplasm in
the S phase.
Pull-down and Surface Plasmon Resonance Experiments
Suggest That Cdk2 but Not Cyclin A Binds Directly to
PCNA—To test a direct interaction with PCNA, Cdk2, and
cyclin A were generated as GST fusion proteins. The GST
fusion proteins were incubated with bacterially expressed
PCNA and isolated by immobilization on glutathione-Sepha-
rose. The washing steps were done with 150 mM NaCl. Bound
PCNA was then detected by immunoblotting with an anti-
PCNA monoclonal antibody (PC10). Fig. 3A shows an interac-
tion between PCNA and Cdk2 but no interaction between
PCNA and cyclin A. The PCNA binding region of RF-Cp145
(RF-C B) and p21 were used as positive controls. The DNA
binding region of RF-Cp145 (RF-C A) and GST were negative
controls (21). Different salt concentrations for washing were
used to test the salt dependence of the interaction between
PCNA and Cdk2 (Fig. 3B). The interaction could resist up to 1
M NaCl and was lost at 2 M, which is characteristic of a hydro-
phobic interaction.
Next, the binding properties of PCNA to Cdk2 were meas-
ured by using a surface plasmon resonance-based assay (IBIS
System, Intersens Instruments BV). Fig. 3C shows sensor-
grams obtained with GST-Cdk2, heat-denatured GST-Cdk2,
and GST injected on a dextran sensor chip coupled with PCNA.
The response (R), expressed in millidegrees, is a measure for
the protein mass at the surface of the sensor chip; binding is
detected as an increased of millidegrees (R) in time. Only
native GST-Cdk2 was able to interact with PCNA. GST and
heat-denatured GST-Cdk2 were boiled and used as negative
controls to exclude unspecific binding of GST and buffer jump,
respectively. The association rate constant (ka) derived from
multiple measurements at different concentrations of GST-
Cdk2 is 8.3 6 3.2 3 105 M21 s21. This ka is in the same range
as the one already described for PCNA/p21 interaction (1.1 3
105 M21 s21; Ref. 22). Taken together, the GST binding exper-
iment and the surface plasmon resonance analysis show a
direct interaction between Cdk2 and PCNA.
Cdk2 Binds to the “Front Side” of PCNA—To map the bind-
ing site of Cdk2 on PCNA, we used mutants of PCNA that were
N-terminally Myc-tagged and transiently overexpressed in 293
cells. The three mutants were constructed by changing resi-
dues of loops exposed on the surface of the PCNA trimer (9).
The mutant S43A/H44A/V45A is mutated in the bC1–bD1 loop,
which forms a part of the hydrophobic pocket on the front side
of the trimer close to where the C termini are located. The
second mutant, Q125A/L126A/G127A/I128A, targets the mid-
dle of the domain-connecting loop, and the third mutant,
V188A/D189A/K190A, targets the loop between bD2 and bD1
on the backside of the torus. Wild type PCNA with either an
N-terminal Myc tag or a C-terminal Myc-His tag was also
overexpressed in the same cell line. Extracts were prepared
from these cells and used in GST pull-down experiments, to see
if the overexpressed mutant and wild type proteins were able to
bind Cdk2. GST-RF-C B was used as a positive control. In
pull-down assays, N-Myc-tagged PCNA was found to interact
strongly with Cdk2 (Fig. 4A), whereas no interaction was ob-
served between Cdk2 and C-Myc-His-PCNA from cell extracts
or bacterially expressed C-His-PCNA. All three mutants were
able to bind Cdk2 (Fig. 4B). This may suggest that the different
mutated regions are not directly involved in the interaction
FIG. 1. PCNA can form a complex with Cdk2 and cyclin A in
HeLa cells in the nucleus. Immunoprecipitations with anti-cyclin A
and anti-Cdk2 antibodies were performed with cytoplasmic and nuclear
extracts of asynchronous HeLa cells as described under “Experimental
Procedures.” The immunoprecipitated samples were loaded on two gels
and tested by immunoblotting using anti-Cdk2 and anti-cyclin A for one
blot and anti-PCNA antibodies for the other. For the input, 2 mg of
extracts were loaded. The negative control (2) was an immunoprecipi-
tation with an anti-GST polyclonal antibody.
FIG. 2. PCNA and Cdk2 form a complex in S phase. A1, flow
cytometry analysis of U2OS cells synchronized in G1 phase by serum
starvation (0.5% FCS) and a release of 2 h. A2, immunoprecipitation
(IP) with anti-Cdk2 antibody using cytoplasmic and nuclear extracts of
HeLa cells in G1 phase as described under “Experimental Procedures.”
B1, flow cytometry analysis of U2OS cells synchronized in S phase,
hydroxyurea block, and 2 h of release. B2, immunoprecipitations with
anti-Cdk2 antibody were performed by using cytoplasmic and nuclear
extracts of HeLa cells in S phase as described under “Experimental
Procedures.” As a control, 2 mg of extracts was loaded. The negative
control (2) was an immunoprecipitation with an anti-GST polyclonal
antibody.
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with Cdk2 or that Cdk2 interacts with a relatively large region
on the PCNA surface. These results suggested that the binding
site of Cdk2 on PCNA is located at the PCNA front side of
where the C termini are located.
A Pull-down Experiment Suggests That PCNA Does Not
Compete with p21 for Cdk2 Binding—To determine if PCNA
and the kinase inhibitor p21cip1/WAF-1 have the same interac-
tion site on Cdk2, p21 was used as a potential competitor of
PCNA for binding wild type Cdk2 in a GST pull-down experi-
ment. From the structure of p27kip1 bound to the Cdk2-cyclin A
complex, it has been shown that the members of the Kip/Cip
family interact with the N-terminal lobe of Cdk2. As described
above, GST-proteins bound to beads were incubated with
PCNA (100 ng) or a mixture of PCNA (100 ng) and p21 (100 ng).
The ability to bind the GST-Cdk2 was determined by immuno-
blot with an anti-PCNA antibody (PC10). As seen in Fig. 5, p21
bound to Cdk2 did not affect the ability of PCNA to interact
with Cdk2, while interacting with Cdk2, indicating that PCNA
does not bind the same site on Cdk2 as on p21.
PCNA Can Bring the Cdk-Cyclin Phosphorylation Activity to
PCNA-interacting DNA Replication Proteins, Replication Fac-
tor C and DNA Ligase I—Next, experiments were designed to
see if the Cdks could phosphorylate proteins involved in DNA
replication. PCNA was immunoprecipitated from HeLa nuclear
extracts, and the activity of the co-immunoprecipitated Cdk-
cyclins was tested in a kinase assay. Histone H1, Lig I, and the
PCNA binding region of RF-C (RF-C B) were used as substrates
(2 mg), since Lig I and RF-C B have many potential Cdk-cyclin
phosphorylation sites. The Cdk2-PCNA complex was able to
phosphorylate histone H1 (Fig. 6A). Phosphorylation of bacte-
rially expressed PCNA binding region of RF-Cp145 (Fig. 6B)
and Lig I (Fig. 6C) was also evident and specific for Cdks, since
the cyclin-dependent kinase inhibitor p21 prevented phospho-
rylation of both PCNA-binding replication protein and the con-
trol protein histone H1. From this experiment we concluded
that PCNA could target Cdk-cyclin to PCNA-binding DNA
replication proteins.
Binding of Cdk2 to DNA Ligase I Is Favored in the Presence
of Equal Amounts of PCNA and DNA Ligase I—To test a
possible direct interaction between Lig I and Cdk2, GST-Cdk2
fusion proteins bound on beads were incubated with bacterially
FIG. 3. Pull-down (A and B) and surface plasmon resonance (C)
experiments show that Cdk2 can bind directly to PCNA. A and B,
GST-Cdk2 fusion protein GST-cyclin A and a control GST-protein were
bound to glutathione-Sepharose beads, incubated with 100 ng of PCNA,
and washed with binding buffer, containing varying concentrations of
salt (B). The pull-down experiment, SDS-polyacrylamide gel electro-
phoresis, and immunoblots were performed as described under “Exper-
imental Procedures.” C, 5 mg each of GST-Cdk2 (1), boiled GST-Cdk2
(2), and GST (3) were passed over a sensor chip on which PCNA was
immobilized as described under “Experimental Procedures.” R is the
response expressed in millidegrees.
FIG. 4. Cdk2 binds close to the C termini of PCNA. GST-Cdk2
fusion protein and control GST-protein were bound on glutathione-
Sepharose beads and incubated with wild type PCNA either N-Myc- or
C-Myc-His-tagged (A) and with the three mutants of PCNA (S43A/
H44A/V45A (SHV43), Q125A/L126A/G127A/I128A (QLGI125), and
V188A/D189A/K190A (VDK188)) (9), all N-Myc-tagged (B). The bound
proteins were solved in SDS sample buffer and separated on SDS-
polyacrylamide gel. The ability of the respective recombinant proteins
to bind PCNA was determined by immunoblotting with the PCNA
antibody PC10 as described under “Experimental Procedures.”
FIG. 5. A pull-down experiment suggests that PCNA does not
compete with p21 to bind Cdk2. GST-Cdk2 wild type fusion proteins
and control GST-proteins were bound on glutathione-Sepharose beads
and incubated with PCNA (100 ng) or a mix of p21 (100 ng) and PCNA
(100 ng). The pull-down experiment, SDS-polyacrylamide gel electro-
phoresis, and autoradiographed immunoblots were performed as de-
scribed under “Experimental Procedures.” The ability of the respective
recombinant proteins to bind PCNA was determined by immunoblot-
ting with anti-PCNA antibody (A) and anti-p21 antibody (B),
respectively.
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expressed Lig I (500 ng) or a mixture of Lig I (500 ng) and
PCNA (500 ng). Bound Lig I was then detected by immunoblot-
ting with an anti-Lig I polyclonal antibody. Fig. 7 shows that
the interaction between Lig I and Cdk2 was favored 5 times in
the presence of an equal amount of PCNA, as compared with
the control reaction in the absence of PCNA.
PCNA Can Stimulate Phosphorylation of DNA Ligase I by
Cdk2-Cyclin A—Finally, phosphorylation of Lig I by pure
Cdk2-cyclin A complex was tested in the presence or absence of
PCNA. Different amounts of Cdk2-cyclin A complex (25, 50,
and 100 ng) and Lig I (100 ng) and different amounts of PCNA
(50, 100, and 200 ng) were first incubated at 4 °C for 1 h, and
the mixture was then tested in a kinase assay. When PCNA
was added in the reaction (Fig. 8), phosphorylation of Lig I was
stimulated. Phosphorylation was increased 4 times with equal
amounts of Cdk2-cyclin A complexes, PCNA, and Lig I (lane 7),
as compared with the control reaction in the absence of PCNA
(lane 5). As a negative control, p21 was added to the reaction.
Inhibition of the assay showed that phosphorylation was spe-
cific to Cdk2-cyclin A complex.
DISCUSSION
A complex with PCNA was identified in nuclear extracts of
HeLa cells by immunoprecipitating cyclin A and Cdk2 (Fig. 1).
However, the ternary complex was not detected in the cyto-
plasm, suggesting that Cdk2 is represented in this compart-
ment of the cell in two pools, namely either bound to PCNA
alone or to cyclin A alone. PCNA-Cdk2 complex is present in
the nucleus throughout the cell cycle and is preferentially
formed during S phase in the cytoplasm (Fig. 2). These results
together with the fact that a direct interaction between PCNA
and Cdk2 is also seen in GST pull-down experiments (Fig. 3A)
and by surface plasmon resonance analysis (Fig. 3C) suggested
that PCNA and Cdk-cyclin could form a complex. Cdk2 did not
bind C-terminally Myc-tagged PCNA (Fig. 4A), suggesting that
the front side of PCNA containing the C terminus is involved in
the interaction with Cdk2. We did not detect competition be-
tween PCNA and p21 for binding to Cdk2, suggesting that
these two proteins bind Cdk2 using distinct interaction sites
(Fig. 5). By immunoprecipitation, we observed that the PCNA-
Cdk2 complex is present in the nucleus both during G1 and S
phases, but during S phase the complex was also detected in
the cytoplasm (Fig. 2). We therefore hypothesize that Cdk2
could be involved in the translocation of PCNA from the cyto-
plasm into the nucleus during S phase, as detected by complex
formation, since PCNA has no nuclear localization sequence.
Alternatively, Cdk2-PCNA complex formation could be inhib-
ited in the cytoplasm during G1 phase, while during S phase
productive complex formation in the cytoplasm could result in
nuclear import of Cdk2-PCNA complexes.
The finding that a Cdk activity brought to PCNA was able to
phosphorylate two DNA replication proteins, the PCNA bind-
ing region of RF-Cp145 (Fig. 6B) and Lig I (Fig. 6C) could be
physiologically significant. A Cdk2-cyclin recognition motif has
been identified in substrate proteins, and p21-like cyclin-de-
pendent kinase inhibitors (23, 24). This recognition motif was
present in the sequence of the retinoblastoma protein (pRb);
the transcription factors E2F1, E2F2, and E2F3; and the Cdk
inhibitor p21, p27, and p57. These findings suggested a recog-
nition step between Cdks-cyclins and substrates preceding
phosphorylation. Lig I has many potential sites of phosphoryl-
ation by Cdk-cyclin, suggesting a phosphorylation of Lig I by
the PCNA-Cdk-cyclin complex (Fig. 6C). Although the putative
FIG. 6. PCNA can bring the Cdk-cyclin phosphorylation activ-
ity to the PCNA-interacting DNA replication proteins, replica-
tion factor C and DNA ligase I. Immunoprecipitation (IP) with
anti-PCNA antibody was performed by using nuclear extracts of HeLa
cells as described under “Experimental Procedures.” The immunopre-
cipitated complexes were used in a kinase assay on histone H1 (control)
(A), the PCNA binding region of RF-Cp145 (RF-C B) (B), and Lig I (C).
The specificity of Cdks was measured by adding the inhibitor protein
p21. The negative control (2) was an immunoprecipitation with the
IgG1,k (MOPC-21) monoclonal antibody described under “Experimental
Procedures.”
FIG. 7. Binding of Cdk2 to DNA ligase I is favored by the
presence of PCNA. GST-Cdk2 wild type fusion proteins and control
GST-proteins were bound on glutathione-Sepharose beads and incu-
bated with Lig I (500 ng) or a mixture of Lig I (500 ng) and PCNA (500
ng). The pull-down experiment, SDS-polyacrylamide gel electrophore-
sis, and autoradiographed immunoblots were performed as described
under “Experimental Procedures.” The ability of the respective GST
proteins to bind Lig I was determined by immunoblotting with anti-Lig
I antibody.
FIG. 8. PCNA can stimulate phosphorylation of DNA ligase I by
Cdk2-cyclin A. Cdk2-cyclin A complex (25, 50, and 100 ng), Lig I (100
ng), and PCNA (50, 100, and 200 ng) were incubated at 4 °C for 1 h and
tested in a kinase assay. The specificity of Cdk2 was measured by
adding the specific Cdk inhibitor p21 (100 ng).
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Cdk2-cyclin binding motif of p27 and p57 (23) is present at the
C-terminal and the N-terminal parts of Lig I, we could demon-
strate in a pull-down experiment that this motif was alone not
sufficient. Consequently, PCNA might be the link between Lig
I and Cdk2 (Fig. 7), suggesting that in a Lig I-PCNA-Cdk2
complex, Lig I can bind to Cdk2 only via an interaction with
PCNA. The other point was the finding that PCNA could stim-
ulate the phosphorylation of Lig I by Cdk2-cyclin A (Fig. 8). Our
data suggest that PCNA may contribute to the recognition step
preceding phosphorylation by acting as a kind of connector for
Cdks-cyclins, which are active on specific target proteins.
PCNA is a trimer, probably interacting with several different
proteins simultaneously. Even if these bind to the same site of
a PCNA monomer, the proteins could still bind different mono-
mers in the PCNA trimer. As PCNA binds a large number of
proteins, it could connect Cdk2 and its substrates. The involve-
ment of Cdk2 in the control of S phase is not completely estab-
lished. It has been shown that a Cdk2-cyclin A complex is
responsible for activating SV40 plasmid replication in mamma-
lian S phase cell extracts (25). Proteins involved in replication
are also substrates for this kinase family. Phosphorylation
regulates the origin binding (26) and DNA helicase activity of T
antigen (12). It has also been shown that polymerase a primase
(13) is unable to initiate SV40 DNA replication in vitro when
phosphorylated. RPA-32 (16) and polymerase d (14) are two
other replication proteins phosphorylated by Cdks, but it is not
known if and how their function is affected. Here we present
evidence that the PCNA binding regions of RF-Cp145 and Lig
I are also substrates of Cdk2. Recently it has been shown that
a strong casein kinase II consensus site of Lig I, which is
localized on the PCNA binding site, is dephosphorylated during
G1 and S phase. Dephosphorylation in these cell cycle phases
correlated with the capacity of Lig I to bind PCNA (27).
Furthermore, in preliminary immunoprecipitations of Myc-
tagged PCNA overexpressed in 293 cells, we could show an
interaction with Cdk4 that is involved in G1 phase and is bound
to cyclin D (data not shown). Indeed, PCNA has been found in
complexes with cyclin D-Cdk4, cyclin E-Cdk2, and cyclin B-
Cdc2, which control the entry points of G1, S, and G2/M phases,
respectively (4). An interaction of PCNA and Cdc2 active in S
phase associated with cyclin A has not yet been investigated,
and consequently the role of PCNA in such complexes has not
yet been established.
Cdks are cell cycle regulatory proteins and involved in the
control of gene expression by the pRb pathway. Our findings of
the phosphorylation of target proteins involved in DNA repli-
cation and the dependence of DNA replication upon Cdk2 ac-
tivity suggest that Cdk2 also controls DNA replication. It will
be interesting to see which step(s) of DNA replication Cdk2
controls. Phosphorylation of a target DNA replication protein
could lead to activation or inhibition in its function. Since DNA
replication is a meticulously organized macromolecular event,
Cdk2 could act in many different steps. The finding of all target
proteins phosphorylated by Cdk2 and its consequences will
eventually allow us to understand the control of DNA replica-
tion by Cdk2 in more detail.
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